Filing Details
- Accession Number:
- 0001192482-18-000385
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-07 16:30:58
- Reporting Period:
- 2018-08-06
- Accepted Time:
- 2018-08-07 16:30:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1621443 | Zynerba Pharmaceuticals Inc. | ZYNE | Pharmaceutical Preparations (2834) | 260389433 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1631682 | M. Suzanne Hanlon | C/O Zynerba Pharmaceuticals, Inc. 80 W. Lancaster Avenue, Suite 300 Devon PA 19333 | Sec, Vp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-06 | 3,800 | $5.80 | 43,693 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.71 to $5.89, inclusive. The reporting person undertakes to provide Zynerba Pharmaceuticals,Inc., any security holder of Zynerba Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth infootnote 1 to this Form 4.
Billionaire Hedge Funds
